Metastatic Renal Cancer
Links shared publicly online about this topic
An Update On Targeted Therapy In Metastatic Renal Cell Carcinoma
medicalnewstoday.com — “UroToday.com - For many years the mainstay of treatment for metastatic renal cell carcinoma (RCC) was immunotherapy, with response rates of from 10% to 20%. An improved understanding of the molec” View full resource at medicalnewstoday.com
Most Recently Shared on August 2, 2010 at 7:37 pm By:
An Update On Targeted Therapy In Metastatic Renal Cell Carcinoma UroToday.com - For many years the mainstay of treatmen.. http://dld.bz/pSsc
More Bladder Cancer Is Metastatic at Diagnosis - Renal and Urology News
renalandurologynews.com — “BARCELONA"Researchers have documented a small but significant stage migration in metastatic bladder cancer between 1988 and 2006.” View full resource at renalandurologynews.com
Most Recently Shared on July 28, 2010 at 10:02 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
More Bladder Cancer Is Metastatic at Diagnosis: BARCELONA—Researchers have documented a small but significant stag... http://bit.ly/9TTok7
Drug Improved Metastatic Bladder Cancer Survival - Renal and Urology News
renalandurologynews.com — “In a recent study, zoledronic acid decreased the incidence of skeletal-related events (SREs) and improved one-year survival in patients with bone metastases from bladder cancer, according to a study.” View full resource at renalandurologynews.com
Most Recently Shared on May 21, 2010 at 5:45 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Drug Improved Metastatic Bladder Cancer Survival: In a recent study, zoledronic acid decreased the incidence of sk... http://bit.ly/9ihEN6
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
jnci.oxfordjournals.org — “Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib” View full resource at jnci.oxfordjournals.org
Most Recently Shared on May 5, 2011 at 2:00 am By:
Michael Fisch Physician, Doctor, Internist, Pain Medicine Physician, and Oncologist
Hypertension as biomarker for treatment efficacy? JNCI: sunitinib data in renal cell #cancer, http://ow.ly/4Nukp, #cardiac #heart
The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell ...: Kidney Cancer Ce...
urotoday.com — “The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell ...: Kidney Cancer Ce...” View full resource at urotoday.com
Most Recently Shared on December 31, 2010 at 10:57 am By:
Urology & Nephrology OW Health
The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell ...: Kidney Cancer Ce... http://bit.ly/fwaqh3
Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
clincancerres.aacrjournals.org — “Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on August 11, 2011 at 3:58 pm By:
Kidney Cancer Health Executive
Your doctor can access the Kidney Cancer Risk Score Calculator developed through this international project that... http://fb.me/18w5DMHit
Pazopanib improved PFS in advanced, metastatic renal cell cancer | HemOncToday
hemonctoday.com — “Pazopanib demonstrated significant improvement in PFS and tumor response rates in patients with treatment-naïve renal cell cancer when c” View full resource at hemonctoday.com
Most Recently Shared on January 28, 2010 at 1:09 pm By:
HemOnc Today Oncology and Health News
#JCO Pazopanib improved PFS in advanced, metastatic renal cell cancer. Data used for FDA drug approval published. http://ow.ly/11kxv
Clinical Trial: Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer - Renal and Urology News
renalandurologynews.com — “A look at the following clinical trial: Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer” View full resource at renalandurologynews.com
Most Recently Shared on March 22, 2010 at 3:17 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Clinical Trial: Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer: A look at the foll... http://bit.ly/bjsWBj
Second-Line Treatment for Metastatic Hormone Refractory Prostate Cancer - Renal and Urology News
renalandurologynews.com — “For the first time, it appears there is a second-line treatment option for men with metastatic hormone refractory prostate cancer.” View full resource at renalandurologynews.com
Most Recently Shared on December 30, 2010 at 6:18 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Second-Line Treatment for Metastatic Hormone Refractory Prostate Cancer: For the first time, it appears there is... http://bit.ly/eQ5bgH
Antifungal Drug May Help Men with Metastatic Prostate Cancer - Renal and Urology News
renalandurologynews.com — “CHICAGO—Itraconazole, an oral antifungal drug, may keep prostate cancer (PCa) from worsening and delay the need for chemotherapy in men with metastatic castration-resistant PCa (mCRPC), according new data presented at the 47th Annual Meeting of the American Society of Clinical Oncology.” View full resource at renalandurologynews.com
Most Recently Shared on June 6, 2011 at 5:15 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Antifungal Drug May Help Men with Metastatic Prostate Cancer: CHICAGO—Itraconazole, an oral antifungal drug, may... http://bit.ly/kFpLMq
Novel Drug Prolongs Survival in Men with Metastatic Prostate Cancer - Renal and Urology News
renalandurologynews.com — “Cabazitazel found superior to mitoxantrone in men with metastatic castration-resistant disease that did not respond to prior treatment with docetaxel.” View full resource at renalandurologynews.com
Most Recently Shared on March 5, 2010 at 10:47 am By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Novel Drug Prolongs Survival in Men with Metastatic Prostate Cancer: TROPIC, a large, multinational study, showed ... http://bit.ly/9w9tsE
Once-Daily Oral Treatment for Metastatic Prostate Cancer Approved - Renal and Urology News
renalandurologynews.com — “The FDA has approved an oral, once-daily medication for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer (CRPC) who have received prior chemotherapy.” View full resource at renalandurologynews.com
Most Recently Shared on May 2, 2011 at 10:12 am By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Once-Daily Oral Treatment for Metastatic Prostate Cancer Approved: The FDA has approved an oral, once-daily medi... http://bit.ly/mdAcA0
Recurrent and Metastatic Breast Cancer
breastcancer.org — “breast cancer recurrence and metastasis” View full resource at breastcancer.org
Most Recently Shared on October 13, 2011 at 9:19 pm By:
Alicia C. Staley Patient Expert and Health Social Media
RT @BCAction: Learn about Metastatic #BreastCancer today! http://t.co/EYovQVK4 Time to talk about this devastating disease. #BCSM #MBC
Novel Therapy for Metastatic Kidney Cancer Developed at VCU Massey Cancer Center
newswise.com — “Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus.” View full resource at newswise.com
Most Recently Shared on December 15, 2010 at 2:03 pm By:
newswise Health Communicator and Health News
Novel Therapy for Metastatic Kidney Cancer Developed at VCU Massey Cancer Center: Researchers at Virginia Common... http://bit.ly/ewe9Qo
Abiraterone Helps Improve Outcomes in Metastatic PCa - Renal and Urology News
renalandurologynews.com — “Abiraterone acetate (Zytiga) plus prednisone significantly improves survival in men with metastatic castration-resistant prostate cancer who have undergone chemotherapy, according to findings reported in The New England Journal of Medicine (2011;364:1995-2005)” View full resource at renalandurologynews.com
Most Recently Shared on July 19, 2011 at 1:26 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Abiraterone Helps Improve Outcomes in Metastatic PCa: Abiraterone acetate (Zytiga) plus prednisone significantly... http://bit.ly/qJNaLV
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
Renal Urology News
Renal and Urology News reports on clinical news for both nephrologists and urologists.
-
Renal Urology News
Renal and Urology News reports on clinical news for both nephrologists and urologists.
Advertisement
